Randomized Studies Inappropriate For Uterine Fibroid Treatment - FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Randomized, controlled clinical trials are both impractical and ill-advised to determine the safety and efficacy of non-extirpative methods of treating uterine fibroids, FDA's Obstetrics and Gynecology Devices Panel agreed Oct. 4.